Continuing Education Activity

Arteriovenous malformations (AVMs) are a developmental anomaly of the vascular system, consisting of tangles of poorly formed blood vessels in which the feeding arteries are directly connected to a venous drainage network without any interposed capillary system. AVMs can occur anywhere in the body, however, brain AVMs are of special concern because of the inherent high risk of bleeding of the abnormal blood vessels that can cause neurological damage. This activity reviews the pathophysiology, presentation, and highlights the role of the interprofessional team in the management of these patients.

Objectives:

• Describe the pathophysiology of AVMs in the brain.
• Outline the presentation of brain AVMs.
• Describe the treatment and management options available for brain AVMs
• Discuss interprofessional team strategies for improving care and outcomes in patients with brain AVMs.

Introduction

Arteriovenous malformations (AVMs) are a developmental anomaly of the vascular system, consisting of tangles of poorly formed blood vessels in which the feeding arteries are directly connected to a venous drainage network without any interposed capillary system.[1][2][3][4]

AVMs can occur anywhere in the body, however, brain AVMs are of special concern because of the inherent high risk of bleeding of the abnormal blood vessels that can cause neurological damage.

Etiology

Not much is known about the etiology of brain AVMs. The cause of brain AVMs is yet unknown, however, it is possibly multifactorial; apparently both genetic mutation and angiogenic stimulation (the physiological process of formation of new blood vessels from pre-existing vessels) playing roles in AVM development. Some believe that AVMs develop in utero. While others advocate an angiopathic reaction, following either a cerebral ischemic or hemorrhagic event (subtypes of stroke) as a primary factor in their development.[5][6][7][8]

Epidemiology

The incidence in the United States is 1.34 per 100,000 person-years, although the actual prevalence rate is higher due to clinically silent disease, as only 12% of AVMs are estimated to become symptomatic. The mortality rate is 10-15% of patients who have a hemorrhage, and morbidity varies from approximately 30-50%. There is no sex predilection. Despite the considered congenital origin of AVMs, the clinical presentation most commonly occurs in young adults.

Pathophysiology

Arteriovenous malformations are composed of a central vascular nidus which is a conglomerate of arteries and veins. There is no intervening capillary bed, and the feeding arteries drain directly into the draining veins by one or multiple fistulae. These arteries lack the normal muscularis layer and the draining veins often appear dilated due to the shunted high-velocity arterial blood flow entering through the fistulae. 

AVMs cause neurological dysfunction through the following three possible pathophysiological mechanisms. Firstly, the abnormal blood vessels have a propensity to bleed resulting in hemorrhage occurring in the subarachnoid space, the intraventricular space, or, more commonly in the brain parenchyma. Secondly, in the absence of hemorrhage, seizures may occur as a consequence of the mass effect of AVM or venous hypertension in draining veins. The third important cause of slowly progressive neurological deficits is attributed to the"steal phenomenon" which is thought to be related to normal brain parenchyma deprivation from nutrients and oxygen, as blood bypasses the normal capillary bed to the malformed arteriovenous channels.

History and Physical

AVMs tend to be clinically asymptomatic in 15% of cases until the presenting event occurs. 

• Approximately 41 to 79 percent present with intracranial hemorrhage. AVMs are the second most common cause of intracranial bleed after cerebral aneurysms, responsible for 10 percent of all cases of subarachnoid hemorrhage. Children are more likely to present with hemorrhage than adults. Hemorrhages are usually intraparenchymal, but can primarily occur in the subarachnoid space. Symptoms due to hemorrhage include loss of consciousness, sudden and severe headache, nausea, vomiting as the coagulated blood makes its way down to be dissolved in the individual's spinal fluid. Reported sequelae caused by local brain tissue damage on the bleed site are also possible, including seizure, hemiparesis, a loss of touch sensation on one side of the body, and deficits in language processing. Minor bleeding may be asymptomatic. Following the arrest of bleeding, most AVM victims recover symptomatically, as the damaged blood vessel repairs itself.
• Studies report seizure as a presenting disorder in 15 to 40% of patients. The risk of seizures increases with cortically-located, large, multiple, and superficial-draining AVMs. Seizures are typically focal, either simple or partial complex, but often show secondary generalization.
• The progressive neurological deficit may occur in 6 to 12% of patients over a few months to several years. A vascular steal syndrome has been hypothesized to cause this presentation, but in most cases, this is related to mass effect, hemorrhage, or seizure. These include seizure, hemiparesis, visual disturbances, loss of sensation in one-half of the body, and aphasia. Minor bleeding can occur with no noticeable symptoms. 
• A headache – There are no specific headache features that associate with AVM, which may be incidental to the headaches.

Evaluation

Brain AVMs are typically first identified in cross-sectional imaging - computed tomogram (CT) or magnetic resonance imaging (MRI). A combination of MRI and angiography are often helpful to plan therapy and predicting the likely success and associated risks of surgical, endovascular, or radiological therapy.

Computed tomography — On non-contrast CT the nidus is blood density and therefore usually somewhat hyperdense compared to adjacent brain, enlarged draining veins, and calcification may be evident. Although many of them are large, however, no mass effect or edema is present unless they bleed. On postcontrast CT especially with CT angiogram, the diagnosis is easily derived with visible feeding arteries, nidus, and draining veins apparent in the so-called "bag of worm" appearance. The exact anatomy of feeding vessels and draining veins can usually be delineated with angiography. The sensitivity of CT to identify brain AVMs in the acute setting of hemorrhage is reduced owing to compression of the nidus by the hematoma so more sensitive techniques such as MRI or angiography are required.

Magnetic resonance imaging — MRI is very sensitive for plotting the location of the brain AVM nidus and often an associated draining vein or any distant bleeding event. Fast flow in a conglomerate of tangled blood vessels generates serpiginous and tubular flow voids seen on bothT1 and T2, however mostly evident on T2 weighted images. Complications like the previous hemorrhage, adjacent brain edema, and atrophy may be seen.

After radiosurgery, MRI can evaluate the regression of the nidus volume, post-therapy edema as well as radiation necrosis in the radiation field.

Angiography — It remains the gold standard for diagnosis and treatment planning. Nidus configuration, its relationship, and drainage to surrounding vessels are precisely evaluated. The presence of an associated aneurysm suggests a higher risk for hemorrhage. Contrast transit time, which relates to the flow state of the lesion, can provide critical information for endovascular treatment planning.

Treatment / Management

Treatment modalities —Invasive management is recommended for younger patients with the presence of one or more of the high-risk features for an AVM rupture, whereas in the case of older individuals with no high-risk features, the usual best treatment is medical management. In these particular patients, anticonvulsants for seizure control and pertinent analgesia for headaches may be the only management required. Several studies report that a history of the previous rupture is one of the most significant risk factors that predict long-term bleeding risk. Other important factors include patient age, AVM location, the presence of aneurysms, size, and other vascular features. Patients with AVMs and intractable epilepsy are also candidates for AVM treatment.[9][10][11][12][13]

Surgical excision — Open microsurgical excision is the mainstay of treatment and offers the cure for patients considered to be at high risk of hemorrhage.

Spetzler-Martin Grade (SMG) scale is commonly employed for the assessment of the risk of surgical morbidity and mortality with brain AVMs. It is a composite score of nidus size (<3 cm, 3-6 cm, >6 cm; 1-3 points), the eloquence of adjacent brain (1 point for lesions located in the brainstem, cerebellar peduncles, thalamus, hypothalamus, or language, sensorimotor, or primary visual cortex), and venous drainage (1 point if any or all of venous drainage is via deep veins, such as basal veins, internal cerebral veins, or precentral cerebellar veins). The higher the score, the higher the associated surgical morbidity and mortality risk.

Radiotherapy and endovascular embolization are not only useful alternatives to surgical treatment in patients at high risk for surgical therapy but can also be useful adjuncts to the main surgical management.

Differential Diagnosis

The differential diagnoses of cerebral AVMs include:

• Carotid/vertebral artery dissection
• Cavernous sinus syndromes and thrombosis
• Cerebral amyloid angiopathy
• Cerebral venous thrombosis
• Dissection syndromes
• Fibromuscular dysplasia
• Intracranial aneurysms
• Migraine and cluster headaches
• Moyamoya disease
• Stroke
• Vein of Galen malformation

Prognosis

There are different scoring systems in order to identify the morbidity and mortality associated with observation vs intervention in different types of cerebral AVMs. The main ones are:

1. Spetzler-Martin scale - for microsurgery
2. Supplementary Spetzler-Martin scale - for microsurgery
3. Pittsburgh radiosurgery-based AVM grading scale
4. Toronto score - for microsurgery
5. Buffalo Score - for endovascular treatment

Complications

The main complications associated with AVMs include:

• Intracranial bleed
• Mass effect
• Seizures
• Steal phenomenon
• Neurological deficits

Deterrence and Patient Education

The patient should be properly educated regarding the chance of intracerebral bleed and seizures if the lesion is being conservatively managed. Also, the fitness to drive should be sorted out.

Enhancing Healthcare Team Outcomes

The diagnosis and management of brain AVM are with an interprofessional team that consists of a neurosurgeon, neurologist, internist, and an invasive radiologist. The follow-up of these patients is usually by the nurse practitioner and primary care provider. The management of brain AVMs depends on the size, location, patient age, and status of the AVM (high risk of rupture). While surgery is the mainstay treatment, embolization is another option. The outcomes of these patients depend on the AVM size, presence of symptoms, location, patient comorbidity, and mental status. Complications following surgery are common and recovery in many patients is prolonged requiring extensive rehab. The most significant risk factor for death is the rupture of the AVM.[2][9][14] (Level V) 

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Claro E, Dias A, Girithari G, Massano A, Duarte MA. Non-traumatic Hematomyelia: A Rare Finding in Clinical Practice. Eur J Case Rep Intern Med. 2018;5(11):000961. [PMC free article: PMC6346806] [PubMed: 30755987]

2.

Wu EM, El Ahmadieh TY, McDougall CM, Aoun SG, Mehta N, Neeley OJ, Plitt A, Shen Ban V, Sillero R, White JA, Batjer HH, Welch BG. Embolization of brain arteriovenous malformations with intent to cure: a systematic review. J Neurosurg. 2020 Feb 01;132(2):388-399. [PubMed: 30717053]

3.

Xu H, Wang L, Guan S, Li D, Quan T. Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience. Neuroradiology. 2019 Apr;61(4):471-478. [PubMed: 30712140]

4.

Heit JJ, Thakur NH, Iv M, Fischbein NJ, Wintermark M, Dodd RL, Steinberg GK, Chang SD, Kapadia KB, Zaharchuk G. Arterial-spin labeling MRI identifies residual cerebral arteriovenous malformation following stereotactic radiosurgery treatment. J Neuroradiol. 2020 Feb;47(1):13-19. [PubMed: 30658138]

5.

Li W, Sun Q, Duan X, Yi F, Zhou Y, Hu Y, Yao L, Xu H, Zhou L. [Etiologies and risk factors for young people with intracerebral hemorrhage]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Nov 28;43(11):1246-1250. [PubMed: 30643071]

6.

Caranfa JT, Baldwin MT, Rutter CE, Bulsara KR. Synchronous cerebral arteriovenous malformation and lung adenocarcinoma carcinoma brain metastases: A case study and literature review. Neurochirurgie. 2019 Feb;65(1):36-39. [PubMed: 30638546]

7.

Khandelwal A, Chaturvedi A, Singh GP, Mishra RK. Intractable brain swelling during cerebral arteriovenous malformation surgery due to contralateral acute subdural haematoma. Indian J Anaesth. 2018 Dec;62(12):984-987. [PMC free article: PMC6299763] [PubMed: 30636801]

8.

Hofman M, Jamróz T, Kołodziej I, Jaskólski J, Ignatowicz A, Jakutowicz I, Przybyłko N, Kocur D, Baron J. Cerebral arteriovenous malformations - usability of Spetzler-Martin and Spetzler-Ponce scales in qualification to endovascular embolisation and neurosurgical procedure. Pol J Radiol. 2018;83:e243-e247. [PMC free article: PMC6323595] [PubMed: 30627242]

9.

Kocer N, Kandemirli SG, Dashti R, Kizilkilic O, Hanimoglu H, Sanus GZ, Tunali Y, Tureci E, Islak C, Kaynar MY. Single-stage planning for total cure of grade III-V brain arteriovenous malformations by embolization alone or in combination with microsurgical resection. Neuroradiology. 2019 Feb;61(2):195-205. [PubMed: 30488257]

10.

Ironside N, Chen CJ, Ding D, Ilyas A, Kumar JS, Buell TJ, Taylor D, Lee CC, Sheehan JP. Seizure Outcomes After Radiosurgery for Cerebral Arteriovenous Malformations: An Updated Systematic Review and Meta-Analysis. World Neurosurg. 2018 Dec;120:550-562.e3. [PubMed: 30149174]

11.

Mosimann PJ, Chapot R. Contemporary endovascular techniques for the curative treatment of cerebral arteriovenous malformations and review of neurointerventional outcomes. J Neurosurg Sci. 2018 Aug;62(4):505-513. [PubMed: 29582979]

12.

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ., British Thoracic Society. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017 Dec;72(12):1154-1163. [PubMed: 29141890]

13.

Cenzato M, Boccardi E, Beghi E, Vajkoczy P, Szikora I, Motti E, Regli L, Raabe A, Eliava S, Gruber A, Meling TR, Niemela M, Pasqualin A, Golanov A, Karlsson B, Kemeny A, Liscak R, Lippitz B, Radatz M, La Camera A, Chapot R, Islak C, Spelle L, Debernardi A, Agostoni E, Revay M, Morgan MK. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien). 2017 Jun;159(6):1059-1064. [PubMed: 28389875]

14.

van Essen MJ, Han KS, Lo RTH, Woerdeman P, van der Zwan A, van Doormaal TPC. Functional and educational outcomes after treatment for intracranial arteriovenous malformations in children. Acta Neurochir (Wien). 2018 Nov;160(11):2199-2205. [PMC free article: PMC6209013] [PubMed: 30191363]

Disclosure: Maria Bokhari declares no relevant financial relationships with ineligible companies.

Disclosure: Syed Rizwan Bokhari declares no relevant financial relationships with ineligible companies.